InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,996.20
(
0.39%
)
US TECH 100
20,552.00
(
0.05%
)
Dow Jones
43,992.89
(
0.60%
)
Brent Oil
73.93
(
-2.03%
)
Bitcoin
76,484.03
(
0.77%
)
Post# of 253557
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 61
Posts 11605
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: microcapfun post# 55503

Sunday, 12/02/2007 7:43:47 AM

Sunday, December 02, 2007 7:43:47 AM

Post# of 253557
""""Onyx will have data on its phase three trial of Nexavar for lung cancer in 2008. If Nexavar is approved for that disease, the two could compete, Liang says"""""

The trial design looks like a hoky genentech trial.

Nexavar arm: CP plus nexavar for 6 cycles and then nexavar forever.

Control arm: CP for 6 cycles and then die. No 2nd or 3rd line treatment allowed.

Only ecog performance 0 and 1 need apply.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up